The 1998 national Belgian consensus meeting on HP-related diseases : an extensive summary.
« HP testing must be regarded as ONE of the important elements of the proper diagnostic work-up of a DISEASE, managed in close cooperation between GP's and specialists » : that's the key message of the national consensus meeting held in CHU Brugmann on February 6th and 7th 1998.
HP testing (usually by 2 direct methods :
RUT-histology) and eradication treatment (ER), in infected patients, are strongly recommended in : 1. Past or current GDU (absolute indication), regardless of activity, complication (s), NSAID intake ; 2. Low-grade MALT Lymphomas (Stage IE1) unequivocally diagnosed, managed and followed-up in specialised centers ; 3. Post endoscopic resection of EGC.
ER is advisable in HP carriers with a family history of gastric cancer.
Chronic atrophic-lymphocytic, giant folds gastritis and hyperplastic polyps are acceptable indications for ER as well as scheduled long-term NSAID treatment in individuals with known HP status.
Systematic ER in HP+patients with fully investigated NUD is not indicated but could be considered in individual patients.
Extra alimentary disorders and auto immune gastritis are no indication and there was no consensus for a « test and treat » policy in patients under 45 yrs old without alarm symptoms.
Systematic screening of asymptomatic individuals is not ecommended.
A correct monitoring of eradication after treatment is recommended, mainly by UBT. (...)
Mots-clés Pascal : Gastrite, Bactériose, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bactérie, Traitement, Gestion, Indication, Protocole thérapeutique, Complication, Acte congrès, Homme, Appareil digestif pathologie, Estomac pathologie
Mots-clés Pascal anglais : Gastritis, Bacteriosis, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bacteria, Treatment, Management, Indication, Therapeutic protocol, Complication, Proceedings, Human, Digestive diseases, Gastric disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0471230
Code Inist : 002B05B02F. Création : 19/02/1999.